(CLOX) Series Portfolios Trust - Ratings and Ratios
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US81752T4866
CLOX: CLOs, High-Rated, Debt Securities, Ultrashort Bonds, Fixed Income
Series Portfolios Trust, traded as CLOX on NYSE ARCA, is an actively managed ETF that focuses on investing at least 80% of its net assets in collateralized loan obligations (CLOs) rated AAA or equivalent by a nationally recognized statistical rating organization (NRSRO) at the time of purchase. This ETF is categorized under Ultrashort Bond and is characterized as non-diversified, indicating a concentrated investment approach.
The investment strategy of CLOX is centered around CLOs, which are financial instruments that represent a claim on the cash flows from a pool of loans, often leveraged loans made to corporations. By targeting AAA-rated CLOs, the fund aims to provide a relatively stable income stream with lower credit risk, as these securities are considered to be of high credit quality. The active management aspect allows the fund to adapt to market conditions, potentially optimizing returns while managing risk.
Analyzing the technical data, the current price of CLOX is $25.40, slightly above its short-term moving averages (SMA20 at $25.30 and SMA50 at $25.23), indicating a positive short-term trend. The long-term SMA200 stands at $24.91, further suggesting that the ETF is in an overall uptrend. The Average True Range (ATR) of 0.21, or 0.82%, indicates relatively low volatility, which is expected given the nature of the investments. The proximity to the 52-week high of $25.47 suggests that the ETF is near its recent peak, potentially indicating strong recent performance.
With Assets Under Management (AUM) of $133.38 million, CLOX has a reasonable size for an ETF, suggesting a certain level of investor interest and liquidity. Given its focus on high-quality CLOs and its non-diversified nature, the funds performance is closely tied to the overall health of the CLO market and the broader credit market conditions.
Forecasting the future performance of CLOX involves analyzing both its technical and fundamental data. Given the current uptrend and the relatively low volatility, it is plausible that CLOX could continue to perform well in the short term, potentially testing or slightly exceeding its current 52-week high. However, the overall direction of interest rates, credit spreads, and the economic outlook will be crucial in determining the funds future performance. If the economic conditions remain stable or improve, and interest rates remain conducive to the CLO market, CLOX could see further gains. Conversely, any significant deterioration in credit quality or unexpected rate changes could negatively impact the fund.
Based on the available data, a potential target for CLOX could be in the range of $25.60 to $26.00, assuming a continuation of the current trend and favorable market conditions. Conversely, a drop below the SMA50 could signal a potential correction, with support around the SMA200 at $24.91. Investors should closely monitor market conditions, interest rate decisions, and credit market health to adjust their strategies accordingly.
Additional Sources for CLOX ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
CLOX ETF Overview
Market Cap in USD | 184m |
Category | Ultrashort Bond |
TER | 0.21% |
IPO / Inception | 2023-07-18 |
CLOX ETF Ratings
Growth Rating | 55.3 |
Fundamental | - |
Dividend Rating | 58.3 |
Rel. Strength | 10.1 |
Analysts | - |
Fair Price Momentum | 26.32 USD |
Fair Price DCF | - |
CLOX Dividends
Dividend Yield 12m | 5.80% |
Yield on Cost 5y | 6.54% |
Annual Growth 5y | 47.18% |
Payout Consistency | 100.0% |
Payout Ratio | % |
CLOX Growth Ratios
Growth Correlation 3m | 89.3% |
Growth Correlation 12m | 96.2% |
Growth Correlation 5y | 99.5% |
CAGR 5y | 7.29% |
CAGR/Max DD 5y | 1.76 |
Sharpe Ratio 12m | 0.50 |
Alpha | 0.27 |
Beta | 0.200 |
Volatility | 1.80% |
Current Volume | 159.7k |
Average Volume 20d | 154k |
As of June 25, 2025, the stock is trading at USD 25.63 with a total of 159,738 shares traded.
Over the past week, the price has changed by +0.65%, over one month by +0.65%, over three months by +1.94% and over the past year by +6.27%.
Partly, yes. Based on ValueRay´s Analyses, Series Portfolios Trust (NYSE ARCA:CLOX) is currently (June 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 55.29 and therefor an somewhat technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CLOX is around 26.32 USD . This means that CLOX is currently overvalued and has a potential downside of 2.69%.
Series Portfolios Trust has no consensus analysts rating.
According to our own proprietary Forecast Model, CLOX Series Portfolios Trust will be worth about 28.7 in June 2026. The stock is currently trading at 25.63. This means that the stock has a potential upside of +11.86%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 28.7 | 11.9% |